19635791_1|19635791|2703|#section_info|0:0|Because both mtGTP synthesis and anaplerotic flux correlate with insulin secretion, we investigated whether the GTP-dependent mitochondrial isoform of PEPCK,|#main_body|GO:0006183|GTP biosynthetic process|#go_definition|NONE|GOA|Pepck(362282)|#gene_synonym
0.7	19635791_1|19635791|0|paper_title|0:0|Phosphoenolpyruvate Cycling via Mitochondrial Phosphoenolpyruvate Carboxykinase Links Anaplerosis and Mitochondrial GTP with Insulin Secretion*|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	19635791_5|19635791|144|abstract|0:0|Here we have investigated whether the mitochondrial isoform of phosphoenolpyruvate carboxykinase (PEPCK-M) is the GTPase linking hydrolysis of mtGTP made by succinyl-CoA synthetase (SCS-GTP) to an anaplerotic pathway producing phosphoenolpyruvate (PEP).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	19635791_313|19635791|58937|DISCUSSION|0:0|Substrate level synthesis of mtGTP by SCS-GTP can provide energy for PEP synthesis from OAA in the mitochondrial matrix by PEPCK-M and thereby link PC flux with TCA cycle flux to stimulate insulin release.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	19635791_327|19635791|60419|Supplementary Material|0:0|mitochondrial PEPCK|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	19635791_18|19635791|1722|abstract|0:0|In particular, beta-cells are known to have notably elevated rates of anaplerotic flux of the carbon from glucose into the mitochondria and back out to pyruvate (pyruvate cycling) that is tightly correlated with insulin secretion (1-4).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	19635791_312|19635791|58937|DISCUSSION|0:0|Similarly, mtGTP synthesis by SCS-GTP, an indicator of TCA flux, is also a potent signal for insulin secretion that leads to reduced ATP levels and ATP synthesis rates (5).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	19635791_124|19635791|21815|RESULTS|0:0|12 and 13)), any PEPCK activity measured in beta-cells will arise from PEPCK-M. INS-1 832/13 cells, unlike islets, have high monocarboxylate transporter activity, so 13C-labeled pyruvate can be used to assess PEPCK-M flux in living cells.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	19635791_283|19635791|51703|DISCUSSION|0:0|The pyruvate-malate cycle involves the anaplerotic production of malate that is then converted directly to pyruvate via the cytosolic or mitochondrial isoform of malic enzyme.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	19635791_3|19635791|144|abstract|0:0|Apart from the canonical KATP-dependent glucose-stimulated insulin secretion (GSIS), there are important KATP-independent mechanisms involving both anaplerosis and mitochondrial GTP (mtGTP).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	19635791_12|19635791|144|abstract|0:0|Given that mtGTP synthesized by SCS-GTP is an indicator of TCA flux that is crucial for GSIS, PEPCK-M is a strong candidate to link mtGTP synthesis with insulin release through anaplerotic PEP cycling.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	19635791_196|19635791|35405|DISCUSSION|0:0|In addition to previous reports suggesting the presence of PEPCK activity, data presented herein indicate 1) there is significant mRNA expression, immunodetectable protein, and enzyme activity of PEPCK-M but not PEPCK-C, 2) there is a substantial metabolic flux of substrate through PEPCK-M in intact cells and islets, and 3) that PEPCK-M is involved in GSIS.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	19635791_269|19635791|48497|DISCUSSION|0:0|However, the emphasis on PEP as a second messenger waned upon the reports of KATP-dependent insulin secretion and that PEPCK (at least PEPCK-C) was not present in islets (13, 55).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	19635791_271|19635791|48497|DISCUSSION|0:0|In agreement, overexpression of  PEPCK in the cytosol of islets actually reduced glucose-stimulated increases in insulin synthesis (secretion was not measured) (57).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
19635791_2|19635791|6141|#section_info|0:0|The reaction was coupled to malate dehydrogenase for detection of NADH oxidation by fluorescence. |#main_body|GO:0006116|NADH oxidation|#go_definition|IDA|GOA|Pck2(361042)|#gene_synonym
##EndOfRet##
19635791_3|19635791|17703|#section_info|0:0|D, PEPCK activity in whole cells as well as isolated mitochondria of INS-1 832/13 cells, rat islets, and hepatocytes using a traditional method measuring NADH oxidation. |#fig_caption|GO:0006116|NADH oxidation|#go_definition|IDA|GOA|Pck2(361042)|#gene_synonym
0.73	19635791_6|19635791|144|abstract|0:0|Although cytosolic PEPCK (PEPCK-C) is absent, PEPCK-M message and protein were detected in INS-1 832/13 cells, rat islets, and mouse islets.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.72	19635791_80|19635791|13753|EXPERIMENTAL PROCEDURES|0:0|2) PEPCK-M is the only significant source of PEPCK activity in islets and INS-1 832/13 cells (nuPEPCK-M+1 >> nuPEPCK-C+1).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.72	19635791_111|19635791|16962|RESULTS|0:0|Western blotting demonstrated no significant PEPCK-C in INS-1 832/13 cells, mouse, or rat islets and confirmed its presence in primary rat hepatocytes and whole rat liver (Fig. 2E).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.72	19635791_124|19635791|21815|RESULTS|0:0|12 and 13)), any PEPCK activity measured in beta-cells will arise from PEPCK-M. INS-1 832/13 cells, unlike islets, have high monocarboxylate transporter activity, so 13C-labeled pyruvate can be used to assess PEPCK-M flux in living cells.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.7	19635791_47|19635791|8167|EXPERIMENTAL PROCEDURES|0:0|Mass isotopologue analysis of PEPCK activity was performed in INS-1 832/13 cells or rat islets preincubated in DMEM base without glucose for 1 h to minimize the amount of unlabeled glycolytic carbon in the cells.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.7	19635791_223|19635791|41693|DISCUSSION|0:0|Here significant PEPCK-M enzyme activity is reported in islets and INS-1 832/13 cells, comparable with the total activity found in hepatocytes.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.69	19635791_165|19635791|30932|RESULTS|0:0|Mitochondrial PEPCK makes PEP in intact rat islets.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.68	19635791_8|19635791|144|abstract|0:0|Novel 13C-labeling strategies in INS-1 832/13 cells and islets measured substantial contribution of PEPCK-M to the synthesis of PEP.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.67	19635791_112|19635791|16962|RESULTS|0:0|In contrast, robust PEPCK-M expression was detected in INS-1 832/13 cells, rat, and mouse islets at a level comparable with that observed in the hepatocytes and liver.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.67	19635791_134|19635791|23695|RESULTS|0:0|Mitochondrial PEPCK makes PEP in INS-1 832/13 cells.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.67	19635791_171|19635791|30932|RESULTS|0:0|B, PEPCK-M activity in intact rat islets using [1,2-13C]glutamine.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.66	19635791_118|19635791|21217|RESULTS|0:0|Intracellular PEPCK-M Flux in INS-1 832/13 Cells|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.66	19635791_159|19635791|30036|RESULTS|0:0|Intracellular PEPCK-M Activity in Rat Islets|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	19635791_183|19635791|33170|RESULTS|0:0|B, PEPCK activity measurement in INS-1 832/13 cells after silencing of PEPCK-M with siRNA1 compared with non-treated cells.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	19635791_209|19635791|39013|DISCUSSION|0:0|Later, while investigating why glyceraldehyde but not pyruvate itself stimulated insulin secretion in islets, no significant PEPCK activity in rat islets was detected despite a seemingly exhaustive analysis (13).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	19635791_139|19635791|23695|RESULTS|0:0|B-D, PEPCK-M flux in INS-1 832/13 cells is enhanced by glucose.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	19635791_151|19635791|29396|RESULTS|0:0|Inhibition of pyruvate kinase by phenylalanine in INS-1 832/13 cells.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	19635791_212|19635791|39013|DISCUSSION|0:0|Despite later reports that pancreatic islets contain PEPCK activity as well as PEPCK protein by Western blot and immunohistochemistry (37, 38), the prevailing conclusion remains that insulin-secreting cells do not contain substantial PEPCK activity.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	19635791_218|19635791|40119|DISCUSSION|0:0|When PEPCK activity was found lacking in rat islets cytosol, a "true" cytosolic fraction devoid of PEPCK-M activity was assayed (13).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	19635791_286|19635791|51703|DISCUSSION|0:0|Although primary tissue is more physiologically relevant than cell lines, given the discrepancy between the observations in INS cells and islets, interpretation of the negative data from rat islets where the cytosolic isoform of malic enzyme was silenced by adenovirus must be considered with caution (60).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	19635791_51|19635791|8167|EXPERIMENTAL PROCEDURES|0:0|beta-Cells in intact islets do not take up pyruvate but do take up glutamine, and even low glucose concentrations sufficiently increase mtGTP synthesis to prevent islet glutamine metabolism (via allosteric inhibition of glutamate dehydrogenase) (8).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	19635791_235|19635791|42748|DISCUSSION|0:0|Using an isoform-specific antibody from a peptide unique to PEPCK-M, PEPCK-M was clearly identified in INS-1 832/13 cells as well as rat and mouse islets at comparable levels with those found in hepatocytes.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	19635791_271|19635791|48497|DISCUSSION|0:0|In agreement, overexpression of  PEPCK in the cytosol of islets actually reduced glucose-stimulated increases in insulin synthesis (secretion was not measured) (57).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
19635791_4|19635791|17703|#section_info|0:0|E, PEPCK activity in the mitochondrial fraction of INS-1 832/13 cells and rat islets compared with glutamate dehydrogenase |#fig_caption|GO:0005739|mitochondrion|#go_definition|IDA|GOA|Pck2(361042)|#gene_synonym
0.76	19635791_80|19635791|13753|EXPERIMENTAL PROCEDURES|0:0|2) PEPCK-M is the only significant source of PEPCK activity in islets and INS-1 832/13 cells (nuPEPCK-M+1 >> nuPEPCK-C+1).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.75	19635791_6|19635791|144|abstract|0:0|Although cytosolic PEPCK (PEPCK-C) is absent, PEPCK-M message and protein were detected in INS-1 832/13 cells, rat islets, and mouse islets.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.74	19635791_223|19635791|41693|DISCUSSION|0:0|Here significant PEPCK-M enzyme activity is reported in islets and INS-1 832/13 cells, comparable with the total activity found in hepatocytes.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.73	19635791_124|19635791|21815|RESULTS|0:0|12 and 13)), any PEPCK activity measured in beta-cells will arise from PEPCK-M. INS-1 832/13 cells, unlike islets, have high monocarboxylate transporter activity, so 13C-labeled pyruvate can be used to assess PEPCK-M flux in living cells.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.72	19635791_47|19635791|8167|EXPERIMENTAL PROCEDURES|0:0|Mass isotopologue analysis of PEPCK activity was performed in INS-1 832/13 cells or rat islets preincubated in DMEM base without glucose for 1 h to minimize the amount of unlabeled glycolytic carbon in the cells.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.72	19635791_134|19635791|23695|RESULTS|0:0|Mitochondrial PEPCK makes PEP in INS-1 832/13 cells.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.71	19635791_111|19635791|16962|RESULTS|0:0|Western blotting demonstrated no significant PEPCK-C in INS-1 832/13 cells, mouse, or rat islets and confirmed its presence in primary rat hepatocytes and whole rat liver (Fig. 2E).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.71	19635791_183|19635791|33170|RESULTS|0:0|B, PEPCK activity measurement in INS-1 832/13 cells after silencing of PEPCK-M with siRNA1 compared with non-treated cells.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.7	19635791_165|19635791|30932|RESULTS|0:0|Mitochondrial PEPCK makes PEP in intact rat islets.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.68	19635791_112|19635791|16962|RESULTS|0:0|In contrast, robust PEPCK-M expression was detected in INS-1 832/13 cells, rat, and mouse islets at a level comparable with that observed in the hepatocytes and liver.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.68	19635791_118|19635791|21217|RESULTS|0:0|Intracellular PEPCK-M Flux in INS-1 832/13 Cells|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.68	19635791_151|19635791|29396|RESULTS|0:0|Inhibition of pyruvate kinase by phenylalanine in INS-1 832/13 cells.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.68	19635791_171|19635791|30932|RESULTS|0:0|B, PEPCK-M activity in intact rat islets using [1,2-13C]glutamine.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.67	19635791_159|19635791|30036|RESULTS|0:0|Intracellular PEPCK-M Activity in Rat Islets|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.66	19635791_8|19635791|144|abstract|0:0|Novel 13C-labeling strategies in INS-1 832/13 cells and islets measured substantial contribution of PEPCK-M to the synthesis of PEP.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.66	19635791_209|19635791|39013|DISCUSSION|0:0|Later, while investigating why glyceraldehyde but not pyruvate itself stimulated insulin secretion in islets, no significant PEPCK activity in rat islets was detected despite a seemingly exhaustive analysis (13).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	19635791_51|19635791|8167|EXPERIMENTAL PROCEDURES|0:0|beta-Cells in intact islets do not take up pyruvate but do take up glutamine, and even low glucose concentrations sufficiently increase mtGTP synthesis to prevent islet glutamine metabolism (via allosteric inhibition of glutamate dehydrogenase) (8).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	19635791_139|19635791|23695|RESULTS|0:0|B-D, PEPCK-M flux in INS-1 832/13 cells is enhanced by glucose.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	19635791_212|19635791|39013|DISCUSSION|0:0|Despite later reports that pancreatic islets contain PEPCK activity as well as PEPCK protein by Western blot and immunohistochemistry (37, 38), the prevailing conclusion remains that insulin-secreting cells do not contain substantial PEPCK activity.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	19635791_1|19635791|0|paper_title|0:0|Phosphoenolpyruvate Cycling via Mitochondrial Phosphoenolpyruvate Carboxykinase Links Anaplerosis and Mitochondrial GTP with Insulin Secretion*|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	19635791_218|19635791|40119|DISCUSSION|0:0|When PEPCK activity was found lacking in rat islets cytosol, a "true" cytosolic fraction devoid of PEPCK-M activity was assayed (13).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	19635791_286|19635791|51703|DISCUSSION|0:0|Although primary tissue is more physiologically relevant than cell lines, given the discrepancy between the observations in INS cells and islets, interpretation of the negative data from rat islets where the cytosolic isoform of malic enzyme was silenced by adenovirus must be considered with caution (60).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	19635791_327|19635791|60419|Supplementary Material|0:0|mitochondrial PEPCK|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	19635791_9|19635791|144|abstract|0:0|As high as 30% of PEP in INS-1 832/13 cells and 41% of PEP in rat islets came from PEPCK-M.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	19635791_235|19635791|42748|DISCUSSION|0:0|Using an isoform-specific antibody from a peptide unique to PEPCK-M, PEPCK-M was clearly identified in INS-1 832/13 cells as well as rat and mouse islets at comparable levels with those found in hepatocytes.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	19635791_271|19635791|48497|DISCUSSION|0:0|In agreement, overexpression of  PEPCK in the cytosol of islets actually reduced glucose-stimulated increases in insulin synthesis (secretion was not measured) (57).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	19635791_184|19635791|33170|RESULTS|0:0|C, time course of M+1 labeled PEP by PEPCK-M. INS-1 832/13 cells were preincubated in DMEM base without glucose for 60 min and then 15 mm glucose with 5 mm [3-13C]pyruvate.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
19635791_5|19635791|18474|#section_info|0:0|was used whereby OAA production is coupled to malate dehydrogenase where NADH oxidation to NAD+ is observed in real time. |#main_body|GO:0006116|NADH oxidation|#go_definition|IDA|GOA|Pck2(361042)|#gene_synonym
0.63	19635791_136|19635791|23695|RESULTS|0:0|Glucose is metabolized via glycolysis to PEP and then to pyruvate (Pyr) by PK before mitochondrial uptake where it is metabolized by the TCA cycle producing OAA via malate dehydrogenase (MDH) or by PC directly to OAA.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	19635791_279|19635791|50325|DISCUSSION|0:0|It is particularly important to note that at the time NMR isotopomer modeling techniques were developed to measure pyruvate cycling, malic enzyme was assumed to be the sole path back to pyruvate (i.e.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	19635791_283|19635791|51703|DISCUSSION|0:0|The pyruvate-malate cycle involves the anaplerotic production of malate that is then converted directly to pyruvate via the cytosolic or mitochondrial isoform of malic enzyme.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	19635791_292|19635791|51703|DISCUSSION|0:0|For cycling to occur, the OAA that is metabolized to malate is then decarboxylated to pyruvate by cytosolic malic enzyme, leaving the acetyl-CoA for lipid synthesis pathways.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	19635791_296|19635791|54041|DISCUSSION|0:0|In this cycle, the citrate/isocitrate flux is diverted to the cytosol via the citrate carrier (CIC), and then eventually NADPH and alpha-KG are made by the action of the cytosolic isoform of isocitrate dehydrogenase (cIDH).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	19635791_268|19635791|48497|DISCUSSION|0:0|PEP was later demonstrated to have the same effect on mitochondrial calcium extrusion as had been seen in other tissues, and it was proposed that PEP stimulated insulin secretion by mobilizing Ca2+ from the mitochondria in an adenine nucleotide transporter-dependent manner (53, 54).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
19635791_6|19635791|19877|#section_info|0:0|mitochondria PEPCK activities were higher in insulin-secreting cells than hepatocytes;|#main_body|GO:0006116|NADH oxidation|#go_definition|IDA|GOA|Pck2(361042)|#gene_synonym
0.68	19635791_80|19635791|13753|EXPERIMENTAL PROCEDURES|0:0|2) PEPCK-M is the only significant source of PEPCK activity in islets and INS-1 832/13 cells (nuPEPCK-M+1 >> nuPEPCK-C+1).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.68	19635791_223|19635791|41693|DISCUSSION|0:0|Here significant PEPCK-M enzyme activity is reported in islets and INS-1 832/13 cells, comparable with the total activity found in hepatocytes.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.67	19635791_6|19635791|144|abstract|0:0|Although cytosolic PEPCK (PEPCK-C) is absent, PEPCK-M message and protein were detected in INS-1 832/13 cells, rat islets, and mouse islets.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.67	19635791_7|19635791|144|abstract|0:0|PEPCK enzymatic activity is half that of primary hepatocytes and is localized exclusively to the mitochondria.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	19635791_212|19635791|39013|DISCUSSION|0:0|Despite later reports that pancreatic islets contain PEPCK activity as well as PEPCK protein by Western blot and immunohistochemistry (37, 38), the prevailing conclusion remains that insulin-secreting cells do not contain substantial PEPCK activity.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	19635791_124|19635791|21815|RESULTS|0:0|12 and 13)), any PEPCK activity measured in beta-cells will arise from PEPCK-M. INS-1 832/13 cells, unlike islets, have high monocarboxylate transporter activity, so 13C-labeled pyruvate can be used to assess PEPCK-M flux in living cells.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	19635791_134|19635791|23695|RESULTS|0:0|Mitochondrial PEPCK makes PEP in INS-1 832/13 cells.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	19635791_271|19635791|48497|DISCUSSION|0:0|In agreement, overexpression of  PEPCK in the cytosol of islets actually reduced glucose-stimulated increases in insulin synthesis (secretion was not measured) (57).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	19635791_112|19635791|16962|RESULTS|0:0|In contrast, robust PEPCK-M expression was detected in INS-1 832/13 cells, rat, and mouse islets at a level comparable with that observed in the hepatocytes and liver.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	19635791_165|19635791|30932|RESULTS|0:0|Mitochondrial PEPCK makes PEP in intact rat islets.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
19635791_7|19635791|19877|#section_info|0:0|mitochondria PEPCK activities were higher in insulin-secreting cells than hepatocytes;|#main_body|GO:0005739|mitochondrion|#go_definition|IDA|GOA|Pck2(361042)|#gene_synonym
0.68	19635791_80|19635791|13753|EXPERIMENTAL PROCEDURES|0:0|2) PEPCK-M is the only significant source of PEPCK activity in islets and INS-1 832/13 cells (nuPEPCK-M+1 >> nuPEPCK-C+1).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.68	19635791_223|19635791|41693|DISCUSSION|0:0|Here significant PEPCK-M enzyme activity is reported in islets and INS-1 832/13 cells, comparable with the total activity found in hepatocytes.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.67	19635791_6|19635791|144|abstract|0:0|Although cytosolic PEPCK (PEPCK-C) is absent, PEPCK-M message and protein were detected in INS-1 832/13 cells, rat islets, and mouse islets.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.67	19635791_7|19635791|144|abstract|0:0|PEPCK enzymatic activity is half that of primary hepatocytes and is localized exclusively to the mitochondria.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	19635791_212|19635791|39013|DISCUSSION|0:0|Despite later reports that pancreatic islets contain PEPCK activity as well as PEPCK protein by Western blot and immunohistochemistry (37, 38), the prevailing conclusion remains that insulin-secreting cells do not contain substantial PEPCK activity.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	19635791_124|19635791|21815|RESULTS|0:0|12 and 13)), any PEPCK activity measured in beta-cells will arise from PEPCK-M. INS-1 832/13 cells, unlike islets, have high monocarboxylate transporter activity, so 13C-labeled pyruvate can be used to assess PEPCK-M flux in living cells.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	19635791_134|19635791|23695|RESULTS|0:0|Mitochondrial PEPCK makes PEP in INS-1 832/13 cells.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	19635791_271|19635791|48497|DISCUSSION|0:0|In agreement, overexpression of  PEPCK in the cytosol of islets actually reduced glucose-stimulated increases in insulin synthesis (secretion was not measured) (57).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	19635791_112|19635791|16962|RESULTS|0:0|In contrast, robust PEPCK-M expression was detected in INS-1 832/13 cells, rat, and mouse islets at a level comparable with that observed in the hepatocytes and liver.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	19635791_165|19635791|30932|RESULTS|0:0|Mitochondrial PEPCK makes PEP in intact rat islets.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
19635791_8|19635791|20306|#section_info|0:0|Virtually all of the PEPCK activity from cells and islets was localized to the mitochondrial fraction when adjusted for leakage of mitochondrial contents into the cytosol fraction by parallel measurements of glutamate dehydrogenase activity from the same samples (Fig. 2E).|#main_body|GO:0005739|mitochondrion|#go_definition|IDA|GOA|Pck2(361042)|#gene_synonym
0.69	19635791_218|19635791|40119|DISCUSSION|0:0|When PEPCK activity was found lacking in rat islets cytosol, a "true" cytosolic fraction devoid of PEPCK-M activity was assayed (13).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.67	19635791_221|19635791|40119|DISCUSSION|0:0|The lack of activity in the mitochondrial fraction could be because either the mitochondria were still intact and reactants could not get in or contaminating mitochondrial outer membrane-associated enolase activity consumed the PEP.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.66	19635791_204|19635791|36544|DISCUSSION|0:0|Some of the differences might be attributed to the age of the rodent (PEPCK-M is prominent early in life) (31, 32, 35), whether they were fed or fasted (fasting or stress favors PEPCK-C since it is glucagon and glucocorticoid driven), mitochondrial isolation techniques (differences arise from hypotonic lysis, sonication, freeze thaw, detergent, and lyophilization) (28, 30, 36), whether leakage of mitochondrial contents into cytosolic fractions was accounted for, or whether the mitochondrial activity was measured directly or as a difference between total and cytosolic.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	19635791_284|19635791|51703|DISCUSSION|0:0|In these reactions mitochondrial malic enzyme reduces NAD+ in the mitochondrial matrix, whereas the cytosolic form reduces NADP+ in the cytosol.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	19635791_7|19635791|144|abstract|0:0|PEPCK enzymatic activity is half that of primary hepatocytes and is localized exclusively to the mitochondria.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	19635791_124|19635791|21815|RESULTS|0:0|12 and 13)), any PEPCK activity measured in beta-cells will arise from PEPCK-M. INS-1 832/13 cells, unlike islets, have high monocarboxylate transporter activity, so 13C-labeled pyruvate can be used to assess PEPCK-M flux in living cells.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	19635791_213|19635791|40119|DISCUSSION|0:0|Retrospectively, these discrepancies may be reconciled on the basis 1) of the presence of two distinct PEPCK gene products (mitochondrial and cytosolic), 2) that islets contain little or no PEPCK-C, and 3) the different assays variably detected the cytosolic and mitochondrial isoforms.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	19635791_286|19635791|51703|DISCUSSION|0:0|Although primary tissue is more physiologically relevant than cell lines, given the discrepancy between the observations in INS cells and islets, interpretation of the negative data from rat islets where the cytosolic isoform of malic enzyme was silenced by adenovirus must be considered with caution (60).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	19635791_39|19635791|5102|EXPERIMENTAL PROCEDURES|0:0|Cytosolic and mitochondrial fractions were assayed simultaneously.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	19635791_47|19635791|8167|EXPERIMENTAL PROCEDURES|0:0|Mass isotopologue analysis of PEPCK activity was performed in INS-1 832/13 cells or rat islets preincubated in DMEM base without glucose for 1 h to minimize the amount of unlabeled glycolytic carbon in the cells.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	19635791_196|19635791|35405|DISCUSSION|0:0|In addition to previous reports suggesting the presence of PEPCK activity, data presented herein indicate 1) there is significant mRNA expression, immunodetectable protein, and enzyme activity of PEPCK-M but not PEPCK-C, 2) there is a substantial metabolic flux of substrate through PEPCK-M in intact cells and islets, and 3) that PEPCK-M is involved in GSIS.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	19635791_271|19635791|48497|DISCUSSION|0:0|In agreement, overexpression of  PEPCK in the cytosol of islets actually reduced glucose-stimulated increases in insulin synthesis (secretion was not measured) (57).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	19635791_18|19635791|1722|abstract|0:0|In particular, beta-cells are known to have notably elevated rates of anaplerotic flux of the carbon from glucose into the mitochondria and back out to pyruvate (pyruvate cycling) that is tightly correlated with insulin secretion (1-4).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	19635791_120|19635791|21266|RESULTS|0:0|Because PEPCK-M is compartmentalized in the mitochondrial matrix where the concentrations of substrate and products may be locally high and different from the cytosol, direct comparison of these activities ex vivo in lysates may be misleading.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	19635791_212|19635791|39013|DISCUSSION|0:0|Despite later reports that pancreatic islets contain PEPCK activity as well as PEPCK protein by Western blot and immunohistochemistry (37, 38), the prevailing conclusion remains that insulin-secreting cells do not contain substantial PEPCK activity.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	19635791_215|19635791|40119|DISCUSSION|0:0|containing both cytosolic and mitochondrial fractions) was assayed (14, 15).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	19635791_220|19635791|40119|DISCUSSION|0:0|When the mitochondrial fraction was studied, intact mitochondria were added to a similar reaction mixture that contained ITP and Mg2+ but with no inhibitors.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	19635791_222|19635791|40119|DISCUSSION|0:0|Mn2+ or Fe2+ did not further stimulate PEPCK activity, but because the combination of Mg2+ and Mn2+ can blunt enzyme activity measurements and ferroactivator (later identified to be glutathione peroxidase) does not activate the mitochondrial fraction, this is not surprising (39).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	19635791_296|19635791|54041|DISCUSSION|0:0|In this cycle, the citrate/isocitrate flux is diverted to the cytosol via the citrate carrier (CIC), and then eventually NADPH and alpha-KG are made by the action of the cytosolic isoform of isocitrate dehydrogenase (cIDH).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	19635791_208|19635791|39013|DISCUSSION|0:0|Early reports of a PEPCK enzymatic activity were described in mouse islets with many of the same characteristics as that of PEPCK from liver (including the dissociation constants and a dependence on Mn2+ but lacking "ferroactivator" or hormonal/nutrient stimulation) (14, 15).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	19635791_210|19635791|39013|DISCUSSION|0:0|Subsequently, as further support for the absence of PEPCK activity, the same group found no demonstrable evidence for gluconeogenesis from labeled pyruvate nor mRNA from PEPCK-C in islets (12).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	19635791_242|19635791|43639|DISCUSSION|0:0|Because there is not an intramitochondrial pool of 2-PG or 3-PG, the identical 13C enrichment of these analytes as PEP demonstrates that the mitochondrial anion pool is small relative to and in rapid communication with the cytosolic pool of PEP (supplemental Fig. S2B).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	19635791_265|19635791|48497|DISCUSSION|0:0|Previously it has been demonstrated that PEPCK-M synthesis of PEP in the mitochondria rapidly leads to export of PEP from such mitochondria and has a maximum matrix concentration of 11 nmol/mg of mitochondria (9).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	19635791_283|19635791|51703|DISCUSSION|0:0|The pyruvate-malate cycle involves the anaplerotic production of malate that is then converted directly to pyruvate via the cytosolic or mitochondrial isoform of malic enzyme.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
19635791_9|19635791|24892|#section_info|0:0|As expected the concentration (combined labeled and unlabeled) of PEP and malate increased with increasing concentrations of glucose. |#main_body|GO:0006108|malate metabolic process|#go_definition|IDA|GOA|Pck2(361042)|#gene_synonym
0.69	19635791_142|19635791|23695|RESULTS|0:0|B, the LC/MS/MS measured concentrations of total malate and PEP (labeled and unlabeled).|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.68	19635791_75|19635791|12941|EXPERIMENTAL PROCEDURES|0:0|As such, the similarities of the natural abundance enrichments of the unlabeled samples with increasing glucose concentrations to the predicted values further supports that the peaks analyzed are the mono-anions of PEP and malate.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	19635791_50|19635791|8167|EXPERIMENTAL PROCEDURES|0:0|To ensure that the [3-13C]pyruvate could contribute label to the PEP precursor pool in the face of increasing glucose concentrations, an extracellular concentration of 5 mm was applied.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	19635791_49|19635791|8167|EXPERIMENTAL PROCEDURES|0:0|As such, [3-13C]pyruvate was used as a tracer entering distal to the irreversible PK step to label the mitochondrial OAA precursor pool of PEPCK-M and kept at a constant concentration with varying concentrations of glucose.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	19635791_74|19635791|12941|EXPERIMENTAL PROCEDURES|0:0|The signal from natural abundance 13C in standards or in samples to which 13C-enriched substrates were not added (Table 1) was as predicted from 1.11% background enrichment (3.33% for PEP and 4.44% for malate) and did not change with increasing glucose concentration (supplemental Fig. S1).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	19635791_155|19635791|29396|RESULTS|0:0|C, the ratio of [PEP M+1] concentration to [Malate M+1] concentration.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	19635791_173|19635791|30932|RESULTS|0:0|The 13C enrichment of the M+1 isotopologue of malate M+1 and PEP are shown.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
19635791_10|19635791|24892|#section_info|0:0|As expected the concentration (combined labeled and unlabeled) of PEP and malate increased with increasing concentrations of glucose. |#main_body|GO:0006090|pyruvate metabolic process|#go_definition|IDA|GOA|Pck2(361042)|#gene_synonym
0.69	19635791_142|19635791|23695|RESULTS|0:0|B, the LC/MS/MS measured concentrations of total malate and PEP (labeled and unlabeled).|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.68	19635791_75|19635791|12941|EXPERIMENTAL PROCEDURES|0:0|As such, the similarities of the natural abundance enrichments of the unlabeled samples with increasing glucose concentrations to the predicted values further supports that the peaks analyzed are the mono-anions of PEP and malate.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	19635791_50|19635791|8167|EXPERIMENTAL PROCEDURES|0:0|To ensure that the [3-13C]pyruvate could contribute label to the PEP precursor pool in the face of increasing glucose concentrations, an extracellular concentration of 5 mm was applied.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	19635791_49|19635791|8167|EXPERIMENTAL PROCEDURES|0:0|As such, [3-13C]pyruvate was used as a tracer entering distal to the irreversible PK step to label the mitochondrial OAA precursor pool of PEPCK-M and kept at a constant concentration with varying concentrations of glucose.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	19635791_74|19635791|12941|EXPERIMENTAL PROCEDURES|0:0|The signal from natural abundance 13C in standards or in samples to which 13C-enriched substrates were not added (Table 1) was as predicted from 1.11% background enrichment (3.33% for PEP and 4.44% for malate) and did not change with increasing glucose concentration (supplemental Fig. S1).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	19635791_155|19635791|29396|RESULTS|0:0|C, the ratio of [PEP M+1] concentration to [Malate M+1] concentration.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	19635791_173|19635791|30932|RESULTS|0:0|The 13C enrichment of the M+1 isotopologue of malate M+1 and PEP are shown.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
19635791_11|19635791|26083|#section_info|0:0|In the presence of 13C-labeled pyruvate, the enrichment of malate was 55%,|#main_body|GO:0006090|pyruvate metabolic process|#go_definition|IDA|GOA|Pck2(361042)|#gene_synonym
0.72	19635791_129|19635791|21815|RESULTS|0:0|Because OAA and malate are in isotopologue equilibrium with each other, the 13C enrichment of the more abundant and less labile malate reflects the enrichment of OAA.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.71	19635791_173|19635791|30932|RESULTS|0:0|The 13C enrichment of the M+1 isotopologue of malate M+1 and PEP are shown.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.66	19635791_292|19635791|51703|DISCUSSION|0:0|For cycling to occur, the OAA that is metabolized to malate is then decarboxylated to pyruvate by cytosolic malic enzyme, leaving the acetyl-CoA for lipid synthesis pathways.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	19635791_279|19635791|50325|DISCUSSION|0:0|It is particularly important to note that at the time NMR isotopomer modeling techniques were developed to measure pyruvate cycling, malic enzyme was assumed to be the sole path back to pyruvate (i.e.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	19635791_283|19635791|51703|DISCUSSION|0:0|The pyruvate-malate cycle involves the anaplerotic production of malate that is then converted directly to pyruvate via the cytosolic or mitochondrial isoform of malic enzyme.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	19635791_87|19635791|13753|EXPERIMENTAL PROCEDURES|0:0|7) Malate is primarily of mitochondrial origin and is in mass isotopologue equilibrium with OAA in both pools (10, 11).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	19635791_136|19635791|23695|RESULTS|0:0|Glucose is metabolized via glycolysis to PEP and then to pyruvate (Pyr) by PK before mitochondrial uptake where it is metabolized by the TCA cycle producing OAA via malate dehydrogenase (MDH) or by PC directly to OAA.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
19635791_12|19635791|26083|#section_info|0:0|In the presence of 13C-labeled pyruvate, the enrichment of malate was 55%,|#main_body|GO:0006108|malate metabolic process|#go_definition|IDA|GOA|Pck2(361042)|#gene_synonym
0.72	19635791_129|19635791|21815|RESULTS|0:0|Because OAA and malate are in isotopologue equilibrium with each other, the 13C enrichment of the more abundant and less labile malate reflects the enrichment of OAA.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.71	19635791_173|19635791|30932|RESULTS|0:0|The 13C enrichment of the M+1 isotopologue of malate M+1 and PEP are shown.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.66	19635791_292|19635791|51703|DISCUSSION|0:0|For cycling to occur, the OAA that is metabolized to malate is then decarboxylated to pyruvate by cytosolic malic enzyme, leaving the acetyl-CoA for lipid synthesis pathways.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	19635791_279|19635791|50325|DISCUSSION|0:0|It is particularly important to note that at the time NMR isotopomer modeling techniques were developed to measure pyruvate cycling, malic enzyme was assumed to be the sole path back to pyruvate (i.e.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	19635791_283|19635791|51703|DISCUSSION|0:0|The pyruvate-malate cycle involves the anaplerotic production of malate that is then converted directly to pyruvate via the cytosolic or mitochondrial isoform of malic enzyme.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	19635791_87|19635791|13753|EXPERIMENTAL PROCEDURES|0:0|7) Malate is primarily of mitochondrial origin and is in mass isotopologue equilibrium with OAA in both pools (10, 11).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	19635791_136|19635791|23695|RESULTS|0:0|Glucose is metabolized via glycolysis to PEP and then to pyruvate (Pyr) by PK before mitochondrial uptake where it is metabolized by the TCA cycle producing OAA via malate dehydrogenase (MDH) or by PC directly to OAA.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
19635791_13|19635791|27105|#section_info|0:0|indicating that PEPCK-M activity was stimulated by glucose despite dilution of the precursor pool.|#main_body|GO:0071333|cellular response to glucose stimulus|#go_definition|IEP|GOA|Pck2(361042)|#gene_synonym
0.62	19635791_50|19635791|8167|EXPERIMENTAL PROCEDURES|0:0|To ensure that the [3-13C]pyruvate could contribute label to the PEP precursor pool in the face of increasing glucose concentrations, an extracellular concentration of 5 mm was applied.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
19635791_14|19635791|27659|#section_info|0:0|the lack of a difference with Phe treatment further supports nuPEPCK-M+1 as the primary metabolic pathway of M+1 PEP from [13C]pyruvate |#main_body|GO:0006090|pyruvate metabolic process|#go_definition|IDA|GOA|Pck2(361042)|#gene_synonym
0.63	19635791_131|19635791|21815|RESULTS|0:0|As the OAA is metabolized to PEP by PEPCK, 100% of the 13C label will be transferred to the respective 2 or 3 position with the loss of unlabeled CO2.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	19635791_126|19635791|21815|RESULTS|0:0|Pyruvate dehydrogenase metabolism of [3-13C]pyruvate with continued TCA cycle flux will lead to a similar labeling pattern of OAA.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
19635791_15|19635791|31919|#section_info|0:0|In contrast, labeled glutamine enriched the M+1 isotopologue of malate to ~33%, whereas that of the PEP M+1 isotopologue reached nearly 7% |#main_body|GO:0006108|malate metabolic process|#go_definition|IDA|GOA|Pck2(361042)|#gene_synonym
##EndOfRet##
19635791_16|19635791|31919|#section_info|0:0|In contrast, labeled glutamine enriched the M+1 isotopologue of malate to ~33%, whereas that of the PEP M+1 isotopologue reached nearly 7% |#main_body|GO:0006090|pyruvate metabolic process|#go_definition|IDA|GOA|Pck2(361042)|#gene_synonym
##EndOfRet##
19635791_17|19635791|32701|#section_info|0:0|as well as by a 75% reduction in the PEPCK activity in whole cells (Fig. 6B).|#main_body|GO:0006116|NADH oxidation|#go_definition|IDA|GOA|Pck2(361042)|#gene_synonym
##EndOfRet##
19635791_18|19635791|34405|#section_info|0:0|Cells were incubated simultaneously with 15 mm glucose and 5 mm [3-13C]pyruvate, and then PEP enrichment was measured at different time points. When PEPCK-M was silenced, both total and 13C-labeled PEP concentrations were significantly reduced, confirming the impact of silencing on metabolism |#main_body|GO:0006090|pyruvate metabolic process|#go_definition|IMP|GOA|Pck2(361042)|#gene_synonym
0.71	19635791_50|19635791|8167|EXPERIMENTAL PROCEDURES|0:0|To ensure that the [3-13C]pyruvate could contribute label to the PEP precursor pool in the face of increasing glucose concentrations, an extracellular concentration of 5 mm was applied.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.7	19635791_141|19635791|23695|RESULTS|0:0|Then 5 mm [3-13C]pyruvate with 0, 3, 7, or 15 mm glucose was added for 45 min before cells were quenched.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.68	19635791_204|19635791|36544|DISCUSSION|0:0|Some of the differences might be attributed to the age of the rodent (PEPCK-M is prominent early in life) (31, 32, 35), whether they were fed or fasted (fasting or stress favors PEPCK-C since it is glucagon and glucocorticoid driven), mitochondrial isolation techniques (differences arise from hypotonic lysis, sonication, freeze thaw, detergent, and lyophilization) (28, 30, 36), whether leakage of mitochondrial contents into cytosolic fractions was accounted for, or whether the mitochondrial activity was measured directly or as a difference between total and cytosolic.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.67	19635791_164|19635791|30081|RESULTS|0:0|Thus, when CO2 is lost to make PEP, only half of the labeled carbon remains so that the PhiPEPCK-M, when [1,2-13C]glutamine is substrate, is calculated as 100 x [2(PEP M+1 APE)/(Malate M+1 APE)].|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.67	19635791_279|19635791|50325|DISCUSSION|0:0|It is particularly important to note that at the time NMR isotopomer modeling techniques were developed to measure pyruvate cycling, malic enzyme was assumed to be the sole path back to pyruvate (i.e.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.66	19635791_268|19635791|48497|DISCUSSION|0:0|PEP was later demonstrated to have the same effect on mitochondrial calcium extrusion as had been seen in other tissues, and it was proposed that PEP stimulated insulin secretion by mobilizing Ca2+ from the mitochondria in an adenine nucleotide transporter-dependent manner (53, 54).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.66	19635791_302|19635791|54041|DISCUSSION|0:0|Although there was a significant ~15% decrease in NADPH/NADP+ ratios when cIDH was silenced, this ratio was the same as that found during maximal GSIS, suggesting that the impaired GSIS under these conditions was not primarily because of the NADPH/NADP+ ratio.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	19635791_287|19635791|51703|DISCUSSION|0:0|This is especially important because only a single titer of one virus was reported versus a scrambled control short hairpin RNA with the absence of supporting functional data such as reductions in enzyme activity or diminished pyruvate cycling and NADPH levels (as had been seen in the cell lines).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	19635791_74|19635791|12941|EXPERIMENTAL PROCEDURES|0:0|The signal from natural abundance 13C in standards or in samples to which 13C-enriched substrates were not added (Table 1) was as predicted from 1.11% background enrichment (3.33% for PEP and 4.44% for malate) and did not change with increasing glucose concentration (supplemental Fig. S1).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	19635791_273|19635791|48497|DISCUSSION|0:0|In the event where the cataplerotically synthesized PEP (via PEPCK-M from anaplerotically generated OAA and mtGTP) is transported out of the mitochondria to join the cytosolic PEP pool, a PEP cycle will, thus, be formed, coupling TCA cycle flux with PC flux (Fig. 1).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	19635791_89|19635791|14880|EXPERIMENTAL PROCEDURES|0:0|PEP is produced during glycolysis and is further metabolized to pyruvate by PK.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	19635791_161|19635791|30081|RESULTS|0:0|Glutamine requires mitochondrial metabolism to generate PEP; hence, any contribution of label to PEP from reverse synthesis from pyruvate by PK is eliminated.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	19635791_99|19635791|15830|EXPERIMENTAL PROCEDURES|0:0|Thus, PEP is treated as a single pool whose composition is determined by the rate of appearance of PEP (nuGlyc+1 + nuPEPCK-M+1) minus the rate of disappearance of PEP (nuPK+1).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	19635791_249|19635791|45403|DISCUSSION|0:0|Furthermore, not only is PEPCK-M flux robust compared with glycolysis, but also it is increased further by glucose-stimulated mitochondrial metabolism (Fig. 3D).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	19635791_81|19635791|13753|EXPERIMENTAL PROCEDURES|0:0|3) The only reactions contributing significant carbon to PEP synthesis are enolase (nuGlyc+1) and PEPCK-M (nuPEPCK-M+1), and there is negligible reverse flux from pyruvate kinase into PEP (nuPK-1).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	19635791_184|19635791|33170|RESULTS|0:0|C, time course of M+1 labeled PEP by PEPCK-M. INS-1 832/13 cells were preincubated in DMEM base without glucose for 60 min and then 15 mm glucose with 5 mm [3-13C]pyruvate.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	19635791_196|19635791|35405|DISCUSSION|0:0|In addition to previous reports suggesting the presence of PEPCK activity, data presented herein indicate 1) there is significant mRNA expression, immunodetectable protein, and enzyme activity of PEPCK-M but not PEPCK-C, 2) there is a substantial metabolic flux of substrate through PEPCK-M in intact cells and islets, and 3) that PEPCK-M is involved in GSIS.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	19635791_286|19635791|51703|DISCUSSION|0:0|Although primary tissue is more physiologically relevant than cell lines, given the discrepancy between the observations in INS cells and islets, interpretation of the negative data from rat islets where the cytosolic isoform of malic enzyme was silenced by adenovirus must be considered with caution (60).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	19635791_293|19635791|51703|DISCUSSION|0:0|Complementary results were observed in both INS-1 cells and islets where citrate lyase activity was inhibited or silenced with no diminishment of insulin secretion, suggesting a nonessential role for this cycle in GSIS (65).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	19635791_308|19635791|54041|DISCUSSION|0:0|Regardless, unlike the two aforementioned pyruvate cycles, the cIDH loop is independent of PEP cycling except in the case where PEP transport via the CIC is interrelated or the carbons from alpha-KG do not return to the TCA cycle.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
19635791_19|19635791|34868|#section_info|0:0|Furthermore, insulin secretion in response to 15 mm glucose was completely reduced to that of control basal secretion when PEPCK-M was silenced by either siRNA, |#main_body|GO:0032024|positive regulation of insulin secretion|#go_definition|IMP|GOA|Pck2(361042)|#gene_synonym
0.66	19635791_293|19635791|51703|DISCUSSION|0:0|Complementary results were observed in both INS-1 cells and islets where citrate lyase activity was inhibited or silenced with no diminishment of insulin secretion, suggesting a nonessential role for this cycle in GSIS (65).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.66	19635791_301|19635791|54041|DISCUSSION|0:0|In support of the importance of this loop, silencing cIDH was accompanied by dramatically diminished GSIS in INS-1 cells and rat islets compared with a scrambled control, although GSIS did not completely correlate with the degree of mRNA suppression.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	19635791_246|19635791|43639|DISCUSSION|0:0|It is of interest that although fructose-1,6-bisphosphosphatase expression is normally low in insulin-secreting cells, it is increased during pathological states of the islet and that overexpression of the enzyme reduces insulin secretion (41).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	19635791_302|19635791|54041|DISCUSSION|0:0|Although there was a significant ~15% decrease in NADPH/NADP+ ratios when cIDH was silenced, this ratio was the same as that found during maximal GSIS, suggesting that the impaired GSIS under these conditions was not primarily because of the NADPH/NADP+ ratio.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	19635791_209|19635791|39013|DISCUSSION|0:0|Later, while investigating why glyceraldehyde but not pyruvate itself stimulated insulin secretion in islets, no significant PEPCK activity in rat islets was detected despite a seemingly exhaustive analysis (13).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	19635791_141|19635791|23695|RESULTS|0:0|Then 5 mm [3-13C]pyruvate with 0, 3, 7, or 15 mm glucose was added for 45 min before cells were quenched.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	19635791_271|19635791|48497|DISCUSSION|0:0|In agreement, overexpression of  PEPCK in the cytosol of islets actually reduced glucose-stimulated increases in insulin synthesis (secretion was not measured) (57).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	19635791_287|19635791|51703|DISCUSSION|0:0|This is especially important because only a single titer of one virus was reported versus a scrambled control short hairpin RNA with the absence of supporting functional data such as reductions in enzyme activity or diminished pyruvate cycling and NADPH levels (as had been seen in the cell lines).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
19635791_20|19635791|56819|#section_info|0:0|Silencing PEPCK-M both reduces nuPEPCK-M+1 as well as blocks GSIS (Fig. 6).|#main_body|GO:0006116|NADH oxidation|#go_definition|IMP|GOA|Pck2(361042)|#gene_synonym
##EndOfRet##
19635791_21|19635791|56819|#section_info|0:0|Silencing PEPCK-M both reduces nuPEPCK-M+1 as well as blocks GSIS (Fig. 6).|#main_body|GO:0032024|positive regulation of insulin secretion|#go_definition|IMP|GOA|Pck2(361042)|#gene_synonym
##EndOfRet##
